Your browser doesn't support javascript.
loading
Efficacy and Outcome of Tofacitinib in Immune checkpoint Inhibitor Colitis.
Bishu, Shrinivas; Melia, Joanna; Sharfman, William; Lao, Christopher D; Fecher, Leslie A; Higgins, Peter D R.
Affiliation
  • Bishu S; Division of Gastroenterology, Department of Medicine, University of Michigan, Ann Arbor, Michigan. Electronic address: bishus@med.umich.edu.
  • Melia J; Division of Gastroenterology, Department of Medicine, John's Hopkins University, Baltimore, Maryland.
  • Sharfman W; Division of Oncology, Department of Medicine, John's Hopkins University, Baltimore, Maryland.
  • Lao CD; Division of Hematology and Oncology, Department of Medicine, University of Michigan, Ann Arbor, Michigan.
  • Fecher LA; Division of Hematology and Oncology, Department of Medicine, University of Michigan, Ann Arbor, Michigan.
  • Higgins PDR; Division of Gastroenterology, Department of Medicine, University of Michigan, Ann Arbor, Michigan.
Gastroenterology ; 160(3): 932-934.e3, 2021 02.
Article in En | MEDLINE | ID: mdl-33096100
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Pyrimidines / Antineoplastic Combined Chemotherapy Protocols / Colitis / Protein Kinase Inhibitors / Immune Checkpoint Inhibitors Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Gastroenterology Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Pyrimidines / Antineoplastic Combined Chemotherapy Protocols / Colitis / Protein Kinase Inhibitors / Immune Checkpoint Inhibitors Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Gastroenterology Year: 2021 Type: Article